TREATMENT OF GOOD-RISK DISSEMINATED NONSEMINOTAMOUS GERM-CELL TUMORS - THE LESS BLEOMYCIN, THE MORE CISPLATIN

被引：9

作者：

CULINE, S ^{[1
]}

MAHJOUBI, M ^{[1
]}

PHILIPPOT, I ^{[1
]}

DROZ, JP ^{[1
]}

机构：

[1] INST GUSTAVE ROUSSY,DEPT MED,39 RUE CAMILLE DESMOULINS,F-94800 VILLEJUIF,FRANCE

来源：

EUROPEAN JOURNAL OF CANCER | 1991年 / 27卷 / 12期

关键词：

D O I：

10.1016/0277-5379(91)90458-P

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：1715 / 1715

页数：1

相关论文

共 4 条

[1] CONTINUED REFINEMENT IN THE TREATMENT OF GERM-CELL TUMOR PATIENTS
BAJORIN, DF
BOSL, GJ
[J]. EUROPEAN JOURNAL OF CANCER, 1991, 27 (06) : 677 - 678
[2] EVALUATION OF OPTIMAL DURATION OF CHEMOTHERAPY IN FAVORABLE-PROGNOSIS DISSEMINATED GERM-CELL TUMORS - A SOUTHEASTERN-CANCER-STUDY-GROUP PROTOCOL
EINHORN, LH
WILLIAMS, SD
LOEHRER, PJ
BIRCH, R
DRASGA, R
OMURA, G
GRECO, FA
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (03) : 387 - 391
[3] LOEHRER PJ, 1991, P AN M AM SOC CLIN, V10, P169
[4] STOTER G, 1987, ECCO, V4